In response to the current situation in the pharmaceutical retail industry, Ke Guoqiang, director and general manager of Dashenlin, said at the performance briefing that the industry is currently in the early stages of supply clearance in the pharmacy industry, and small to medium chains and single pharmacies are rapidly exiting. This trend is mainly due to a combination of factors: declining consumption power, strengthened supervision, and the growing competitive advantage of leading chains. In this context, enterprises that operate in accordance with the law, have refined management capabilities, are rich in supply chain resources, and have sufficient scale effects will gain greater market share, and industry concentration will further increase.

In response to the current situation in the pharmaceutical retail industry, Ke Guoqiang, director and general manager of Dashenlin, said at the performance briefing that the industry is currently in the early stages of supply clearance in the pharmacy industry, and small to medium chains and single pharmacies are rapidly exiting. This trend is mainly due to a combination of factors: declining consumption power, strengthened supervision, and the growing competitive advantage of leading chains. In this context, enterprises that operate in accordance with the law, have refined management capabilities, are rich in supply chain resources, and have sufficient scale effects will gain greater market share, and industry concentration will further increase.